All Topics
All Topics
Technology
Technology
Design
Design
Programming
Programming
Science
Science
News
News
Gaming
Gaming
Entertainment
Entertainment
Business
Business
Finance
Finance
Sports
Sports
Health
Health
Food
Food
Travel
Travel
Art
Art
Music
Music
Books
Books
Education
Education
Politics
Politics
Personal
Personal
No algorithm. No AI slop. No ads. Just RSS. Pro-human. Indie writers. Real journalism. Open web. Chronological. Hand toasted.

Study evaluates procurement biopsy and machine perfusion for kidney transplant outcome prediction using OPTN database

By

Lung-Yi (Felix) Lee1,2 Send email to [email protected]

9h ago· 31 min readenInsight

Summary

This retrospective cohort study analyzed data from the Organ Procurement and Transplantation Network database (2014-2022) to evaluate how procurement biopsy findings (glomerulosclerosis levels) and machine perfusion parameters together predict outcomes for kidney transplant recipients. The study included 13,962 adult recipients of solitary kidneys with a Kidney Donor Profile Index of 35% to 85%. Kidneys were categorized by glomerulosclerosis levels (low ≤10%, intermediate 11%-20%, high >20%) and perfusion parameters (good vs. poor). The research aims to determine whether combining these two assessment methods provides better prognostic information for allograft outcomes than either method alone.

Key quotes

· 3 pulled
Procurement biopsy and machine perfusion parameters can be utilized to assess donor kidney quality, but information may be incongruent.
Using the Organ Procurement and Transplantation Network database from 2014 to 2022, we performed a retrospective cohort study of all adult recipients of solitary kidneys with a Kidney Donor Profile Index of 35% to 85%, which were biopsied and machine-perfused (N = 13 962).
The biopsies were separated into 'low' (≤10%), 'intermediate' (11%-20%), and 'high' (>20%) glomerulosclerosis (GS).
Snippet from the RSS feed
Procurement biopsy and machine perfusion parameters can be utilized to assess donor kidney quality, but information may be incongruent. Using the Organ Procurement and Transplantation Network database from 2014 to 2022, we performed a retrospective cohort

You might also wanna read